BSTC Financial Facts

Diluted net income (loss) per share: 0.08
Operating income (loss): 875.66K
See Full Income Statement

Deferred tax assets: 99.24K
Additional paid-in capital: 22.39M
See Full Balance Sheet

BioSpecifics Technologies Corp. (BSTC) Earnings

  |   Expand Research on BSTC
Next EPS Date 11/12/14 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate +63.4% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +8.8% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/11/14 Q214 $0.09$0.12 -$0.03$2.7M$2.91M N/A Details
5/8/14 Q114 $0.12$0.07 +$0.05$2.8M$2.46M N/A Details
8/9/12 Q212 $0.11$0.07 +$0.04$2.6M$2.5M N/A Details
3/9/12 Q411 $0.01N/A N/A $2.6M$1.1M N/A Details
11/8/11 Q311 $0.04N/A N/A $1.9M$1M N/A Details
3/11/11 Q410 $0.02-$0.04 +$0.06$1.1M$1.38M N/A Details